Abstract
Cord blood banking has been the focus of many medical centers as it can provide a virtually unlimited source of ethnically-diverse stem-cell donors. In addition, its recent use in several regenerative medicine clinical trials has further spurred the motivation to collect and bank these stem cells. In the current study, we review the latest developments in cord blood banking. We have banked over 195,000 collections at our facility. Collections were processed by either Ficoll or AXP methodologies. An average 95% processing efficiency was obtained. The overall failure rate was less than 4% in terms of samples containing too few cells to be clinically useful. Processed samples were frozen in cryovials or bags and banked in a liquid nitrogen Dewar. In conclusion, it is possible to simply and reproducibly harvest, process, and bank cord blood samples using current technology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
